Tempur Sealy International, Inc. TPX is slated to report fourth-quarter 2019 results on Feb 13, before the opening bell.In the last reported quarter, the company’s adjusted earnings of $1.30 per share beat the Zacks Consensus Estimate by 15% and revenues of $821 million outpac
Omnicom OMC reported fourth-quarter 2019 earnings per share of $1.89 (on an adjusted basis) which beat the Zacks Consensus Estimate by 2 cents. Earnings increased 12 cents year over year.
Hess Corporation HES has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at HES given that, according to its RSI reading of 29.51, it is now in oversol
Genesco Inc. GCO has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at GCO given that, according to its RSI reading of 28.85, it is now in oversold te
SVB Leerink analysts have crunched the numbers, and they say that Paul Hudson, the new CEO of the French drug giant Sanofi, is right in his predictions for the company’s monoclonal antibody Dupixent.
The coronavirus outbreak has brought along some new uncertainty to the Chinese economy and Alibaba stock—often considered a proxy for the country’s huge consumer market.
The Zacks Metal Products - Procurement and Fabrication industry primarily comprises metal processing and fabrication services providers. Most of the industry participants are engaged in conversion, manufacturing and fabrication of metal into end products. Important fabricated me
Johnson & Johnson’s JNJ subsidiary, Janssen, announced that it has submitted a supplemental biologics license application (sBLA) to the FDA for the label expansion of its multiple myeloma drug, Darzalex (daratumumab). The sBLA is seeking label expansion of Darzalex in comb
Itau Unibanco Holding S.A. ITUB posted recurring earnings of R$7.3 billion ($1.77 billion) in fourth-quarter 2019, up 12.6% year over year. Including non-recurring items, net income came in at R$7.5 billion ($1.82 billion), up 20.6%.
Investors are always looking for stocks that are poised to beat at earnings season and Molson Coors Beverage Company TAP may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
Investors are always looking for stocks that are poised to beat at earnings season and Shopify Inc. SHOP may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Shopify is seeing favorable earn
Academy Awards, better known as Oscars, used be as popular a television event as the Super Bowl. But this year’s Academy Awards saw a drop in viewership of 3 million compared to last year. However, analysts argue that last year’s releases like Black Panther and A Star is Bor
Investors are always looking for stocks that are poised to beat at earnings season and Moody's Corporation MCO may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Moody's is seeing favorabl
Investors are always looking for stocks that are poised to beat at earnings season and Manulife Financial Corporation MFC may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Manulife is see
Investors are always looking for stocks that are poised to beat at earnings season and Equinix, Inc. EQIX may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Equinix is seeing favorable ear
Martin Marietta (MLM) came out with quarterly earnings of $2.09 per share, missing the Zacks Consensus Estimate of $2.18 per share. This compares to earnings of $1.66 per share a year ago. These figures are adjusted for non-recurring items.
Charles River Laboratories (CRL) came out with quarterly earnings of $2.01 per share, beating the Zacks Consensus Estimate of $1.83 per share. This compares to earnings of $1.49 per share a year ago. These figures are adjusted for non-recurring items.